Sk Telecom Company, Ltd.

Daewoong Pharmaceutical Co., Ltd.

Jin Seok Kang

Jong Sun Kim

Jeong Jin Choi

Chin Sung Park

Seung Wook Lim

Young Hyo Yu

Jeom Soon Shim

Jong Keun Chung

Seung Hee Han

Byoung Kwang Lee

Seung Yeob Lee

The present disclosure relates to a nucleic acid analysis apparatus using a cartridge which can simplify the nucleic acid extraction and applicable to a molecular diagnostic POCT equipment. The nucleic acid analysis device includes a stage on which a cartridge is mountable, a nucleic acid extraction unit, and a control unit. The nucleic acid extraction unit performs a nucleic acid extraction through crushing of the sample, the cell disruption, and the nucleic acid purification as well as a nucleic acid amplification. The control unit controls the stage and the nucleic acid extraction unit so that the nucleic acid extraction through the crushing of the sample, the cell disruption, and the nucleic acid purification as well as the nucleic acid amplification are collectively performed.

Nucleic acid analysis apparatus using cartridge

The present disclosure provides a cartridge for use in nucleic acid extraction and a nucleic acid extraction method which can simplify a nucleic acid extraction process and can be applicable to a point-of-care testing (POCT). The cartridge includes a chamber module, an air valve module, and a liquid valve module. The chamber module includes a plurality of chambers for extracting nucleic acids from a sample including a pretreatment chamber in which the sample is crushed and homogenization, cell disruption, and purification are performed. The air valve module is installed on the chamber module to control a pressure required to move a fluid between the plurality of chambers. The liquid valve module is installed below the chamber module to move the fluid between the plurality of chambers.

Cartridge for nucleic acid extraction and nucleic acid extraction method

The present invention relates to a topical composition containing human epidermal growth factor (hEGF) and polyoxyethylene-polyoxypropylene copolymer having a viscosity of 4-10 cps at 37&deg; C, 60 rpm as the base for topical formulation to improve the wound healing ability of hEGF.

Topical composition containing human epidermal growth factor

Growing community of inventors

Seoul, South Korea

Jin Seok Kang